227 related articles for article (PubMed ID: 28847847)
1. Long Noncoding RNA MEG3 Is an Epigenetic Determinant of Oncogenic Signaling in Functional Pancreatic Neuroendocrine Tumor Cells.
Iyer S; Modali SD; Agarwal SK
Mol Cell Biol; 2017 Nov; 37(22):. PubMed ID: 28847847
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic regulation of the lncRNA MEG3 and its target c-MET in pancreatic neuroendocrine tumors.
Modali SD; Parekh VI; Kebebew E; Agarwal SK
Mol Endocrinol; 2015 Feb; 29(2):224-37. PubMed ID: 25565142
[TBL] [Abstract][Full Text] [Related]
3. Long Noncoding RNA Meg3 Regulates Mafa Expression in Mouse Beta Cells by Inactivating Rad21, Smc3 or Sin3α.
Wang N; Zhu Y; Xie M; Wang L; Jin F; Li Y; Yuan Q; De W
Cell Physiol Biochem; 2018; 45(5):2031-2043. PubMed ID: 29529600
[TBL] [Abstract][Full Text] [Related]
4. MEG3 Suppresses Human Pancreatic Neuroendocrine Tumor Cells Growth and Metastasis by Down-Regulation of Mir-183.
Zhang YY; Feng HM
Cell Physiol Biochem; 2017; 44(1):345-356. PubMed ID: 29132136
[TBL] [Abstract][Full Text] [Related]
5. MEG3 Long Noncoding RNA Contributes to the Epigenetic Regulation of Epithelial-Mesenchymal Transition in Lung Cancer Cell Lines.
Terashima M; Tange S; Ishimura A; Suzuki T
J Biol Chem; 2017 Jan; 292(1):82-99. PubMed ID: 27852821
[TBL] [Abstract][Full Text] [Related]
6.
Terashima M; Ishimura A; Wanna-Udom S; Suzuki T
J Biol Chem; 2018 Nov; 293(47):18016-18030. PubMed ID: 30262664
[TBL] [Abstract][Full Text] [Related]
7. MEG3 long noncoding RNA regulates the TGF-β pathway genes through formation of RNA-DNA triplex structures.
Mondal T; Subhash S; Vaid R; Enroth S; Uday S; Reinius B; Mitra S; Mohammed A; James AR; Hoberg E; Moustakas A; Gyllensten U; Jones SJ; Gustafsson CM; Sims AH; Westerlund F; Gorab E; Kanduri C
Nat Commun; 2015 Jul; 6():7743. PubMed ID: 26205790
[TBL] [Abstract][Full Text] [Related]
8. Coordinated silencing of the Sp1-mediated long noncoding RNA MEG3 by EZH2 and HDAC3 as a prognostic factor in pancreatic ductal adenocarcinoma.
Han T; Zhuo M; Yuan C; Xiao X; Cui J; Qin G; Wang L; Jiao F
Cancer Biol Med; 2020 Nov; 17(4):953-969. PubMed ID: 33299646
[TBL] [Abstract][Full Text] [Related]
9. LncRNA MEG3 inhibits the progression of prostate cancer by facilitating H3K27 trimethylation of EN2 through binding to EZH2.
Zhou Y; Yang H; Xia W; Cui L; Xu R; Lu H; Xue D; Tian Z; Ding T; Cao Y; Shi Q; He X
J Biochem; 2020 Mar; 167(3):295-301. PubMed ID: 31790140
[TBL] [Abstract][Full Text] [Related]
10. lncRNA KHPS1 Activates a Poised Enhancer by Triplex-Dependent Recruitment of Epigenomic Regulators.
Blank-Giwojna A; Postepska-Igielska A; Grummt I
Cell Rep; 2019 Mar; 26(11):2904-2915.e4. PubMed ID: 30865882
[TBL] [Abstract][Full Text] [Related]
11. Pro-oncogenic Roles of HLXB9 Protein in Insulinoma Cells through Interaction with Nono Protein and Down-regulation of the c-Met Inhibitor Cblb (Casitas B-lineage Lymphoma b).
Desai SS; Kharade SS; Parekh VI; Iyer S; Agarwal SK
J Biol Chem; 2015 Oct; 290(42):25595-608. PubMed ID: 26342078
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA MEG3 regulates LATS2 by promoting the ubiquitination of EZH2 and inhibits proliferation and invasion in gallbladder cancer.
Jin L; Cai Q; Wang S; Wang S; Mondal T; Wang J; Quan Z
Cell Death Dis; 2018 Oct; 9(10):1017. PubMed ID: 30282996
[TBL] [Abstract][Full Text] [Related]
13. Down-regulated lncRNA MEG3 promotes osteogenic differentiation of human dental follicle stem cells by epigenetically regulating Wnt pathway.
Deng L; Hong H; Zhang X; Chen D; Chen Z; Ling J; Wu L
Biochem Biophys Res Commun; 2018 Sep; 503(3):2061-2067. PubMed ID: 30103943
[TBL] [Abstract][Full Text] [Related]
14. Structural characterization of maternally expressed gene 3 RNA reveals conserved motifs and potential sites of interaction with polycomb repressive complex 2.
Sherpa C; Rausch JW; Le Grice SF
Nucleic Acids Res; 2018 Nov; 46(19):10432-10447. PubMed ID: 30102382
[TBL] [Abstract][Full Text] [Related]
15. Meg3 Non-coding RNA Expression Controls Imprinting by Preventing Transcriptional Upregulation in cis.
Sanli I; Lalevée S; Cammisa M; Perrin A; Rage F; Llères D; Riccio A; Bertrand E; Feil R
Cell Rep; 2018 Apr; 23(2):337-348. PubMed ID: 29641995
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA MEG3 inhibits breast cancer growth via upregulating endoplasmic reticulum stress and activating NF-κB and p53.
Zhang Y; Wu J; Jing H; Huang G; Sun Z; Xu S
J Cell Biochem; 2019 Apr; 120(4):6789-6797. PubMed ID: 30556250
[TBL] [Abstract][Full Text] [Related]
17. LncRNA-MEG3 inhibits cell proliferation of endometrial carcinoma by repressing Notch signaling.
Guo Q; Qian Z; Yan D; Li L; Huang L
Biomed Pharmacother; 2016 Aug; 82():589-94. PubMed ID: 27470401
[TBL] [Abstract][Full Text] [Related]
18. LncRNA-MEG3 inhibits cell proliferation and invasion by modulating Bmi1/RNF2 in cholangiocarcinoma.
Li J; Jiang X; Li C; Liu Y; Kang P; Zhong X; Cui Y
J Cell Physiol; 2019 Dec; 234(12):22947-22959. PubMed ID: 31119760
[TBL] [Abstract][Full Text] [Related]
19. LncRNA SNHG17 promotes gastric cancer progression by epigenetically silencing of p15 and p57.
Zhang G; Xu Y; Wang S; Gong Z; Zou C; Zhang H; Ma G; Zhang W; Jiang P
J Cell Physiol; 2019 Apr; 234(4):5163-5174. PubMed ID: 30256413
[TBL] [Abstract][Full Text] [Related]
20. Expression of the lncRNA Maternally Expressed Gene 3 (MEG3) Contributes to the Control of Lung Cancer Cell Proliferation by the Rb Pathway.
Kruer TL; Dougherty SM; Reynolds L; Long E; de Silva T; Lockwood WW; Clem BF
PLoS One; 2016; 11(11):e0166363. PubMed ID: 27832204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
